Hand grip strength in patients with advanced cancer: A prospective study

Sara Hadzibegovic,Jan Porthun,Alessia Lena,Pia Weinländer,Laura C. Lück,Sophia K. Potthoff,Lukas Rösnick,Ann‐Kathrin Fröhlich,Luisa Valentina Ramer,Frederike Sonntag,Ursula Wilkenshoff,Johann Ahn,Ulrich Keller,Lars Bullinger,Amir A. Mahabadi,Matthias Totzeck,Tienush Rassaf,Andrew J.S. Coats,Stefan D. Anker,Eric J. Roeland,Ulf Landmesser,Markus S. Anker,Stephan von Haehling
DOI: https://doi.org/10.1002/jcsm.13248
2023-06-16
Abstract:Background Hand grip strength (HGS) is a widely used functional test for the assessment of strength and functional status in patients with cancer, in particular with cancer cachexia. The aim was to prospectively evaluate the prognostic value of HGS in patients with mostly advanced cancer with and without cachexia and to establish reference values for a European‐based population. Methods In this prospective study, 333 patients with cancer (85% stage III/IV) and 65 healthy controls of similar age and sex were enrolled. None of the study participants had significant cardiovascular disease or active infection at baseline. Repetitive HGS assessment was performed using a hand dynamometer to measure the maximal HGS (kilograms). Presence of cancer cachexia was defined when patients had ≥5% weight loss within 6 months or when body mass index was <20.0 kg/m2 with ≥2% weight loss (Fearon's criteria). Cox proportional hazard analyses were performed to assess the relationship of maximal HGS to all‐cause mortality and to determine cut‐offs for HGS with the best predictive power. We also assessed associations with additional relevant clinical and functional outcome measures at baseline, including anthropometric measures, physical function (Karnofsky Performance Status and Eastern Cooperative of Oncology Group), physical activity (4‐m gait speed test and 6‐min walk test), patient‐reported outcomes (EQ‐5D‐5L and Visual Analogue Scale appetite/pain) and nutrition status (Mini Nutritional Assessment). Results The mean age was 60 ± 14 years; 163 (51%) were female, and 148 (44%) had cachexia at baseline. Patients with cancer showed 18% lower HGS than healthy controls (31.2 ± 11.9 vs. 37.9 ± 11.6 kg, P
medicine, general & internal,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?